Baptist Health South Florida announced that it has signed an agreement with IBA, a leading provider of proton therapy solutions for the treatment of cancer. The agreement includes the purchase, installation and maintenance of a proton therapy system at Baptist Health’s Miami Cancer Institute, currently under construction. Proton therapy is an advanced treatment that beams radiation directly to the tumor to destroy cancer cells while avoiding healthy surrounding tissues.IBA will equip Miami Cancer Institute with its Proteus®PLUS three-gantry room configuration, including next-generation Pencil Beam Scanning capability. The $80 million contract for combined equipment and services, including long-term operations and maintenance supplied by IBA, is part of Baptist Health’s $430 million investment in the future of cancer care with its state-of-the-art Miami Cancer Institute.
Miami Cancer Institute, scheduled to open in 2016, will consolidate under one roof outpatient clinical services, a dedicated cancer research facility and signature technology platforms, including the first proton therapy center in South Florida. It is expected to treat its first patient with proton therapy in 2017.
